Does the DIO2 Thr92Ala (rs225014) genotype consistently reduce T4-to-T3 conversion and alter serum T3 levels?

The claim that evidence linking the DIO2 rs225014 (Thr92Ala) genotype to reduced T4-to-T3 conversion and altered serum T3 levels is inconsistent across studies is strongly supported by scientific evidence. This inconsistency is primarily explained by tissue-specific genetic expression and the varying physiological states of the studied cohorts.

Mechanistic insights

• Reduced enzyme efficiency: Functional studies demonstrate that the DIO2 Thr92Ala (rs225014) variant decreases the catalytic activity of the type 2 deiodinase enzyme, impairing intracellular conversion of thyroxine (T4) to active triiodothyronine (T3).
• Tissue-specific effects: This intracellular defect is highly localized. Reduced enzymatic efficiency is documented in the brain, placenta, and brown adipose tissue, whereas skeletal muscle remains largely unaffected.
• Organelle stress: The Ala92-D2 variant is also linked to the accumulation of the mutant protein in the endoplasmic reticulum, triggering endoplasmic reticulum (ER) stress and activation of the unfolded protein response (UPR) in brain tissues.

Clinical and physiological evidence

• Baseline euthyroid and general populations: In healthy euthyroid individuals and typical hypothyroid populations receiving standard levothyroxine (LT4) therapy, the rs225014 polymorphism does not consistently alter baseline circulating serum T3, T4, or T3:T4 ratios.
• Physiological stress and specific cohorts: Alterations in serum thyroid hormone profiles become apparent under clinical challenges. Patients with the homozygous Ala/Ala (CC) genotype who have undergone thyroidectomy or are on high-dose thyroid-stimulating hormone (TSH) suppression therapy show modest but significant reductions in circulating T3 levels and lower T3/T4 ratios.

Bottom line

• While the DIO2 Thr92Ala (rs225014) genotype causes a functional, intracellular impairment in T4-to-T3 conversion and triggers ER stress, its effect on circulating serum T3 levels is inconsistent and typically only manifests under physiological stress or specific clinical conditions, such as post-thyroidectomy.